Pain and inflammation are linked with a number of pathological conditions. Several studies are in progress worldwide to find natural healing agents with better safety profile. Our current study was aimed to evaluate Alangium salvifolium (family: Alangeaceae) derived analgesic compounds for therapeutic drug discovery by computational approach. Literature based studies were used to explore the compounds of A. salvifolium. Ligands were prepared by following the appropriate procedures and finally in silico molecular docking analysis performed by GOLD 4.2. After post docking analysis, salviifosides A of Alangium salvifolium was found to have interaction on COX-2 protein by obtaining highest fitness score 50.64 and molecular interaction suggests that it could be a potent anti-inflammatory compound and it may be worth for further clinical trials.
INTRODUCTION
Pain as a form of Inflammation, is suffered by almost everybody during their lifetime (Kennedy, 2007) . Inflammation is the defense response of body, characterized by redness, swelling, heat, pain, and loss of function to eliminate or limit the spread of an injurious agent (Riedel et al., 2014) . It involves a cascade of events elicited by numerous stimuli that include infectious agents, ischemia, thermal and physical injury, and antigen-antibody interaction (Khan et al. 2014) . Cyclooxygenases (COX) or prostaglandin endoperoxide synthase (PGHS) exists in two isoforms COX-1 and COX-2, are the key enzymes in the synthesis of prostaglandins, the main mediators of inflammation, pain and increased body temperature (hyperpyrexia) (Watson et al., 2000) . While both isoform catalyse the same reactions, COX-1 is a constitutive enzyme in most cells-its activity is not changed once the cell is fully grown. Conversely, COX-2 normally present in insignificant amounts is inducible by cytokines, growth factor and other stimuli during the inflammation response.
It is believed that eicosanoids produced by COX-1 participate in physiologic functions such as secretion of mucosa, haemostasis and maintenance of renal function, while those produced by COX-2 leads to inflammatory other pathological changes (Kulkarni et al., 2000; Hinz and Brune, 2002) . Nonsteroidal antiinflammatory drugs (NSAIDs) produce their therapeutic effects through inhibition of COX, the enzyme that makes prostaglandins. Non selective inhibition of COX iso-enzyme leads to not only beneficial therapeutic effects but also a number of detrimental effects. Beneficial effects are due to inhibition of COX-2 and detrimental effects are due to inhibition of physiological COX-1 (Hinz and Brune, 2000; Urban, 2000) .
Recently, a class of anti-inflammatory medications has been developed that primarily inhibits COX-2 while sparing the enzymatic activity of COX-1 at therapeutic dosages. Two medications that predominantly inhibit only COX-2, rofecoxib and celecoxib, are currently available by prescription in the United State, India and Bangladesh (Hinz and Brune, 1999; Everts et al., 2000) .
The use of coxib drugs such as rofecoxib and valdecoxib were withdrawn from the market in 2004 and 2005, respectively, because of increased risk of heart attacks and strokes with long term use (Mason et al., 2006; Mason et al., 2007) . Given the need for more effective and/or less toxic pain therapies, a great deal of . emphasis has been placed on identifying novel molecular targets that could form the basis for new analgesics. Natural products, including medicinal plants, have been the primary source for obtaining new drugs with therapeutic potential throughout history. It is estimated that approximately half of the drugs in use are derived from natural products. According to the World Health Organization (WHO), poverty and lack of access to modern medicine leads from 65% to 80% of the world population in developing countries to critically depend on plants for primary health care Muccillo-Baisch et al., 2010) . In this context, at first, we designed our study to screen out a potent analgesic compounds of Alangium salvifolium. A. salvifolium Wang (syn. Alangium lamarckii) family: Alangeaceae, also called as Ankola, is extensively cultivated in India and Bangladesh. It is a popular folk medicine and has been studied for its anti-microbial, anti-fertility, cardiotonic, anti-diabetic, anticancer, diuretic, laxative, and antiepileptic activity (Sharma et al., 2011; Ahad et al., 2012) . Evidence revealed that it showed a wide range activity against nociception and inflammation (Sharma et al., 2011; Ahad et al., 2012; Zahan et al., 2013) . Earlier studies reported that its leaves contain compound like salicin, kaempferol, salviifosides A-C (Tran et al., 2009), analgimarckine and ankorine (Battersby et al., 1966) . Interaction of these compounds against the active site of COX-2 enzyme and find out a potent selective COX-2 blocker was our main approach the study which is done by in silico molecular docking analysis (Ghosh et al., 2006; Dash et al., 2014) .
MATERIALS AND METHODS Ligands Preparation
From the literature review, all compounds like salicin, kaempferol, salviifosides A-C, analgimarckine, ankorine along with celecoxib were drawn in Symyx Draw 4.0 and then prepared for docking using the Sybyl 7.3 Molecular Modeling Suite of Tripos, Inc. 3D conformations were generated using Concord 4.0 (Hevener et al., 2009) , hydrogen atoms were added and charges were loaded using the Gasteiger and Marsili charge calculation method (Hristozov et al., 2007) . The individual ligand was minimized with the Tripos Force Field prior to docking using the Powell method with an initial Simplex (Osolodkin et al., 2011) optimization and 1000 iterations or gradient termination at 0.01 kcal/(mol*A). Input ligand file format was mol2 for all docking programs investigated.
Protein preparation and Active Site Determination
The crystal structure COX-2 (pdb id : 6 COX) enzyme was collected protein data bank (Berman et al., 2000) . Enzymes was prepared according to the docking protocol of Gold.
The active site of these enzymes was identified according to the giving information Kurumbail et al. (1996) .
Docking using GOLD (Genetic Optimization for Ligand Docking)
GOLD utilizes genetic algorithm to explore the rotational flexibility of receptor hydrogens and ligand conformational flexibility (Jones et al., 1997) . In GOLD docking was carried out using the wizard with default parameters population size (100); selection pressure (1.1); number of operations (10,000); number of islands (1); niche size (2); and operator weights for migrate (0), mutate (100) , and crossover (100) were applied.
The active site with a 10 Å radius sphere was defined by selecting an active site residue of protein. Default Genetic Algorithm settings were used for all calculations and a set of 10 solutions were saved for each ligand. GOLD was used by a GoldScore fitness function. GoldScore is a molecular mechanism like function and has been optimized for the calculation of binding positions of ligand. It takes into account four terms: Fitness = S (hb_ext) + 1.3750*S (vdw_ext) + S (hb_int) + 1.0000*S (int) S (int) = S (vdw_int) + S (tors) Where, S hb_ext is the protein-ligand hydrogen bonding and S vdw_ext are the vanderwaals interactions between protein and ligand. S hb_int are the intramolecular hydrophobic interactions whereas S vdw_ int is the contribution due to intra molecular strain in the ligand.
RESULT
Structure-functional relationship of the compounds of A. salvifolium's leaves along with celecoxib was evaluated to know their biological activity against the COX-2 using the 3D structure of the receptor retrieved from protein data bank site of COX-2 enzyme (pdb code: 6COX).
For this the docked binding mode was established to link the docking score function with these selected compounds and protein. Analysis of the binding pattern between COX-2 protein and ligands suggested that the binding pattern also varied with the ligand nature ( Fig. 1 and 2) .
The results of all compounds were established (Table 1 ) by GOLD scoring parameter. The compound obtained the highest score was further subjected to analyse. The binding mode was compared with standard selective drugs including celecoxib which was done by Accelrys discovery studio visualize 3.5 version shown in table 2. The highest fitness score was obtained by salviifosides A which was 50.64. 
DISCUSSION
Advances in computational techniques have enabled virtual screening to ave a positive impact on the drug discovery process. Virtual screening utilizes docking and scoring of each compound from a dataset and the technique used is based on predicting the binding modes and binding affinities of each compound in the dataset by means of docking to an X-ray crystallographic structure (Franca et al., 2013) .
In our present study, by means of gold docking, we docked all compounds from A. salvifolium with active site of COX-2 enzyme and salviifosides A was found to give most significant binding score with compare to other compounds. Critical evaluation of molecular docking analysis reported in (Table 2) suggested that salviifosides A has the same interaction as like as celecoxib.
The obtained docking data is in accordance with reported data on synthetic compounds where amino acid residues such as HIS , LEU 531 associated with A chain of COX-2 protein were involved for protein-ligand complementarily activity (Kurumbail et al., 1996; Krishna et al., 2013) . In our docking result salviifosides A was found to having three hydrogen bonding with TYR
355
, GLN 192 , and VAL 523 which clearly indicates that it has a good effect in COX-2 inhibition. COX selectivity can be pursued by designing ligands targeted to interact with the non-conserved residues of the two enzymes. This observation further confirms that salviifosides A may be an effective tricyclic anti-inflammatory compound especially with respect to COX-2 protein mediated inflammation compared to other traditional NSAID drugs (Llorens et al., 2002) .
CONCLUSION
The development of novel compounds with biological activity is an urgent need. In the present study phytocompounds of A. salvifolium were successfully docked into the COX-2 protein for drug interaction study to have a track in the ongoing race between drug development and new drugs especially new compounds which are more important for the discovery of new hits using molecular methods. The Fitness scores of all compounds were calculated using the GOLD software. Though the binding pattern of ligands with COX-2 differed respect to H-bonding, fitness score values substantiate the hypothesis that salviifosides A has the potentiality to selectively inhibit the COX-2 protein.
Hence, it is concluded that that salviifosides A could be a potent ant inflammatory target molecule against COX-2 which may be worth for further clinical trials.
